PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today, PDL BioPharma Inc's share price is $5.11. PDL BioPharma Inc's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2015 was $0.48. Hence, PDL BioPharma Inc's Price-to-Free-Cash-Flow Ratio for today is 10.65.
During the past 13 years, PDL BioPharma Inc's highest Price-to-Free-Cash-Flow Ratio was 388.73. The lowest was 4.53. And the median was 11.09.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of PDL BioPharma Inc was 37.10% per year.
During the past 13 years, PDL BioPharma Inc's highest 3-Year average Free Cash Flow per Share Growth Rate was 1227.10% per year. The lowest was 0.00% per year. And the median was -41.50% per year.
PDL BioPharma Inc's Price-to-Free-Cash-Flow ratio for today is calculated as
|Price-to-Free-Cash-Flow Ratio||=||Share Price||/||Free Cash Flow per Share (TTM)|
PDL BioPharma Inc's Share Price of today is $5.11.
PDL BioPharma Inc's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2015 was 0.46 (Sep. 2014 ) + 0.02 (Dec. 2014 ) + 0 (Mar. 2015 ) + 0 (Jun. 2015 ) = $0.48.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, managements decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
PDL BioPharma Inc Annual Data
PDL BioPharma Inc Quarterly Data
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.